The effects of pyrimethamine on endogenous DX2 or AIMP2 were also analyzed by immunoblotting, and the specific decrease of DX2, not AIMP2, protein level was frequently observed in the pyrimethamine-treated tumor tissues (Figure 5f,g). The gene discussed is AIMP2; the disease is neoplasm.